Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial (Q34049203)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial |
scientific article |
Statements
1 reference
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial (English)
1 reference
Pamela J Atherton
1 reference
Patricia C Griffin
1 reference
Amanda R Moraska
1 reference
Amit Sood
1 reference
Shaker R Dakhil
1 reference
Jeff A Sloan
1 reference
Debra Barton
1 reference
Jason J Suh
1 reference
David B Johnson
1 reference
Aneela Ali
1 reference
Peter T Silberstein
1 reference
Steven F Duane
1 reference
Charles L Loprinzi
1 reference
12 July 2010
1 reference
1 reference
28
1 reference
23
1 reference
3673-3679
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference